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Lysosomal stabilityThe abundance of dead macrophages in close proximity to HOCl-modiﬁed proteins in advanced atheroscle-
rotic plaques implicates HOCl in the killing of macrophages and the formation of the necrotic core region.
The mechanism of HOCl mediated death of macrophages was unknown, so using human monocyte derived
macrophages (HMDM) we here have shown that HOCl causes a rapid necrotic cell death characterized by
loss of MTT reduction, cellular ATP and cell lysis without caspase-3 activation in HMDM cells. The HOCl
causes a rise in cytosolic calcium level via the plasma membrane L- and T-type calcium channels and endo-
plasmic reticulum RyR channel. Blocking of the calcium channels or the addition of calpain inhibitors pre-
vents the HOCl mediated loss of mitochondrial potential, lysosome failure and HMDM cell death. Blocking
MPT-pore formation with cyclosporin A also prevents the loss of mitochondrial membrane potential, lyso-
somal destabilization and HMDM cell death. Blocking the calcium mitochondrial uniporter with ruthenium
red also blocks the loss of mitochondrial potential but only at high concentrations. HOCl appears to cause
HMDM cell death through destabilization of cytosolic calcium control resulting in the failure of both the mi-
tochondria and lysosomes.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Hypochlorous acid (HOCl) is a potent oxidant secreted by activated
phagocytic cells at sites of inﬂammation. HOCl is generated by the en-
zyme myeloperoxidase (MPO), which catalyzes the oxidation of chlo-
ride ions by hydrogen peroxide. HOCl plays a central role in the killing
ofmicroorganisms at sites of inﬂammation [1–2] due to its high reactivity
with a range of biomolecules including nucleotides [3], ATP [4], lipids
[5], amino acid side residues [6], ascorbate [7], glutathione [8] and pro-
tein thiols [9]. Thiswide range of reactivity has also implicatedHOCl as a
possible cause of injury to the surrounding host cells and tissues during
inﬂammation [10].
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l rights reserved.been implicated in the growth of the necrotic core of advanced athero-
sclerotic plaques [11]. MPO and 3-chlorotyrosine, a speciﬁc marker of
HOCl oxidation of proteins, have been foundwithin atherosclerotic pla-
ques rich in dead macrophages [12–13]. Macrophages have also been
reported to generateMPO, but not at the levels recorded for neutrophils
[13]. HOCl appears to be a signiﬁcant oxidant towhichmacrophages are
exposed to andmay be oneof the causes ofmacrophage cell deathwith-
in atherosclerotic plaques.
High concentrations of HOCl kill cells by generally oxidizing and lys-
ing the cells. At the lower, more physiological concentration generated
by neutrophils (20–400 μM) [14], HOCl attacks speciﬁc sites on and
within the cells triggering a variety of cell death mechanisms depending
on the cell type. HOCl damage to neuronal cells causes a rise in cytosolic
calcium ion level triggering calpain activation, lysosome rupture and cell
death [15]. In endothelial cells, HOCl triggers apoptosis through a rapidly
decreased endothelial Bcl-2 and cytochrome c release [16] and caspase-3
activation [17]. With HEPG2 and human fetal liver cells, HOCl causes
mitochondrial permeability transition (MPT) pore formation triggering
caspase-3 activation through cytochrome c release [18]. The mechanism
by which HOCl triggers cell death in macrophages is not known.
Macrophage cell death has been described by both necrotic and
apoptotic mechanisms [19]. We have previously shown that HOCl
causes large amounts of protein oxidation in U937 cells leading to
cell death [20]. Treatment of themonocyte like U937 cells with aqueous
peroxyl radicals causes caspase inactivation, glutathione loss and necro-
sis [21]. Oxidized low density lipoproteins cause caspase-independent
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while nitric oxide donors induce caspase activation in J774mousemac-
rophage cell line by inducing hydrogen peroxide formation [25]. In this
study, we show that HOCl induces cell necrosis in HMDM cells by trig-
gering a rise in cytosolic calcium level, MPT-mediated mitochondrial
membrane potential (ΔΨm) loss, calpain activation and lysosomedesta-
bilization. These results provide a novel insight into the mechanisms of
HOCl-mediated cell death at inﬂammatory sites.
2. Materials and methods
2.1. Materials
All tissue culture plastic ware was supplied from Greiner Bio-one
(Germany) through Raylab New Zealand Ltd. except for the 12-well
adherent cell culture plates, which were supplied by Nunc (Kam-
strupvej, Denmark) through In Vitro, New Zealand. Reagents and che-
micals were of analytical grade or better and obtained from BDH
Chemicals New Zealand Ltd. or Sigma Chemical Company (USA). All
solutions were prepared using ion-exchanged ultra-ﬁltered water,
which was produced using a NANOpure ultrapure water system
from Barnstead/Thermolyne (IA/USA). Granulocyte-macrophage colony
stimulating factor (GM-CSF) was a generous gift from the Haematology
group of the Christchurch Hospital. Molecular weight marker was pro-
vided by Fermentas International Inc. (Canada). Complete, Mini prote-
ase inhibitor cocktail tablet was supplied from Roche (Germany).
Calpeptin, SJA6017, cyclosporin A, ﬂuo-3-acetoxymethyl (AM) ester
and tetramethylrhodamine methyl ester (TMRM) were obtained from
Merck (Germany). Acridine orange was supplied from Invitrogen
(USA). The Bicinchoninic acid protein determination kit for protein
quantiﬁcation was supplied from Pierce Biotechnology Inc. (USA).
2.2. Human monocyte-derived macrophage cell culture
Human monocyte derived macrophages (HMDM) were prepared
using unlinked blood donated by hemochromatosis patients at the
NZ Blood Bank (Riccarton Road, Christchurch) under ethics approval
CTY/98/07/069 from the New Zealand Upper South B Ethics Commit-
tee. Monocytes were isolated from human blood by density gradient
centrifugation in the presence of Lymphoprep™ (Axis-Shield PoC AS
(Oslo, Norway)) as described by the manufacturer, and washed four
times in sterile phosphate buffered saline (PBS) containing 150 mM
sodium chloride and 10 mM sodium dihydrogen orthophosphate pH
7.4 [26]. After 40 hour incubation in serum free RPMI-1640 in non-
adherent plates at 37 °C, 5% CO2, cellswere plated into 12-well adherent
plates from Nunc at a cell density of 5×106 cells/well in RPMI-1640
media supplemented with 10% heat-inactivated human serum, 100 U/
ml penicillin and 100 μg/ml streptomycin. The cells were also plated
on 22×22 mm cover slips (Marienfeld) at 5×106 cells/cover slip,
which were placed in 6-well suspension culture plates at 1 cover slip/
well. Prior to use, the cover slips were sterilized by immersion in 96%
ethanol under aseptic conditions followed by exposure UV light for
15 min. The plates were left undisturbed at room temperature for 1 h,
allowing the cells to attach to the cover slip, before adding one extra
ml of the RPMI-1640 media with human serum into each well. GM-
CSF at 3 μg/ml was added to the media on the ﬁrst day after plating
but not added during subsequent media changes, which occurred
every three days. The monocytes were incubated at 37 °C, 5% CO2 and
differentiated into adherent macrophages over 7 to 14 days.
2.3. Cell treatment
HOCl (Clorogene Supplies, Petone) concentration was determined
by absorbance at 292 nm, pH 12 using the extinction coefﬁcient
350 M−1 cm−1[27]. HOCl was diluted to ﬁnal concentrations in sterile
Earle's balanced salt solution (EBSS) (Invitrogen, USA) just beforeaddition to cells. When required, the EBSS was supplemented with
0.68 mM CaCl2 to give the same concentration as in RPMI-1640
media. This media is referred to as calcium-supplemented EBSS while
the straight EBSS buffer without CaCl2 supplementationwill be referred
to as calcium-free EBSS.
For the majority of experiments HMDM cells were incubated at
37 °C with HOCl for 10 min in either calcium-supplemented EBSS or
calcium-free EBSS. For some experiments cells were pre-incubated
with different calcium metabolism modiﬁers. After treatment, the
cells were washed three times with PBS and incubated with the
RPMI-1640 media with human serum for the time periods stated.
2.4. Cellular metabolic activity
HMDM cell viability was measured by the reduction of 3-(4,5-
dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) [28].
Intracellular ATP levels were measured by reverse phase ion pair-high
performance liquid chromatography (HPLC) [29] using a Shimadzu
10A series HPLC with a SPD-M20A UV/Vis detector. For there to be suf-
ﬁcient ATP to be detected, 3wells of 5×106 cells/well HMDMcellswere
combined together by scraping with a total of 125 μl cold 0.07 M per-
chloric acid. After the sonication for 1 min and incubation on ice for
30 min, the cell lysates was centrifuged at 20,800 g for 5 min at 4 °C to
remove proteins. The resulting supernatant was neutralized with
12.5 μl of 2 M potassium carbonate. After centrifugation, 40 μl superna-
tant was injected onto a reverse phase 5 μm ODS (C18), 250×4.6 mm,
5 μm column (Phenomenex) and ATP was detected by absorbance at
254 nm with comparison to standards of known concentration. ATP
level in each sample was normalized for protein content.
Intracellular glutathione was measured using a light sensitive and
cell-permeable ﬂuorescent dye monobromobimane (MBB) that binds
to thiol groups, especially glutathione [30]. The resulting ﬂuorescent
glutathione-MBB adducts were detected by HPLC analysis.
2.5. Caspase-3 detection by Western blot analysis
HMDM cells after HOCl treatment were collected using ice cold
lysis buffer (40 mM HEPES, 50 mM NaCl, 1 mM EDTA, 1 mM EGTA
and 1× protease inhibitor cocktail, pH 7.4) and incubated on ice for
30 min. After protein analysis of the cell lysates and protein precipita-
tion with ice cold acetone, 90 μg protein samples were dissolved in
cracker buffer (0.125 M Tris–HCl (pH 6.8), 1% (w/v) sodium dodecyl
sulfate, 20% (w/v) glycerol, 0.1% (w/v) bromophenol blue, 2% (v/v) β-
mercaptoethanol and 0.5 mM EDTA). The protein samples were sepa-
rated in a 4–12% gradient polyacrylamide gel and transferred to a
0.45 μm-pore size nitrocellulose membrane (Invitrogen, USA). Immu-
nodetections were performed using the primary antibody mouse
monoclonal IgG2a and the secondary antibody goat anti-mouse IgM
HRP-conjugate (Santa Cruz Biotechnology Inc., USA). Equal loading
of proteins was conﬁrmed by re-probing the nitrocellulose mem-
brane with mouse monoclonal antibodies against β-actin (Sigma
Chemical Company, USA) and peroxidase-conjugated sheep anti-
mouse IgG (Amersham Biosciences, England). Signals were detected
using Supersignal West Dura chemiluminescence (Pierce Biotechnolo-
gy Inc., USA) and exposure to Syngene Chemigenius-2 bioimaging sys-
tem using Genesnap software (Global, NZ). Caspase-3 enzymatic
activation was measured by monitoring the change in ﬂuorescence
(λex 370 nm/λem 440 nm) during the hydrolysis of the synthetic sub-
strate acetyl-Asp-Glu-Val-Asp-7-Amido-4-methyl-coumarin (Ac-
DEVD-AMC) [31].
2.6. Fluorescence microscopy measurements
All microscopy investigation was carried out using HMDM cells
grown on cover slips placed directly into the tissue culture well. The
cells were viewed using a Zeiss AxioImager.M1 epiﬂuorescent
Fig. 1. Loss of HMDM cell viability after HOCl treatment. A) Varying concentrations of
HOCl were given to HMDM cells in calcium-supplemented EBSS for 10 (△), 30 (□)
or 60 min (○). After 20 hour incubation in RPMI-1640 media with human serum, the
cells were analyzed for cell viability by MTT reduction. B) HMDM cells were treated
with 100 (△), 150 (□) and 200 μM (○) HOCl for 10 min then the media was changed
to RPMI-1640 with human serum and incubated for the time intervals indicated before
cell viability was determined as MTT reduction. C) HMDM cells were stained with PI
after treatment with increasing HOCl concentrations for 10 min. The cells were viewed
under a ﬂuorescence microscope and the ﬂuorescence intensities were converted to
numerical values. The data were expressed as percentages of the respective controls
in calcium-supplemented EBSSwithoutHOCl. Signiﬁcance is indicated from the respective
controls where no HOCl was added, except for B where signiﬁcance is indicated from the
zero time for each concentration.
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ferential Interference Contrast (DIC) condenser. Cells were viewed
using 40× Plan-NEOFLUAR objective. The images were captured
using a Zeiss AxioCam HRc CCD camera with AxioVision Rel. 4.5 soft-
ware (1300×1030 pixel resolution) and processed with Adobe
Photoshop 8.0. The strength of the ﬂuorescence was converted to nu-
merical values using the online software ImageJ, supplied by National
Institute of Health, USA, by measuring the intensities of three ran-
domly selected views.
Changes in cytosolic calcium concentrations were measured by
pre-incubating HMDM cells with 10 μM ﬂuo-3-acetoxymethyl (AM)
ester for 40 min, followed by exposure to HOCl for 10 min. After
washing with PBS and placing in EBSS, cells were visualized after exci-
tation with blue light (λex 488 nm) and photographing the green ﬂuo-
rescence (λem 530 nm) of the cytosolic ﬂuo-3 bound with calcium [32].
Lysosomal stability was measured by its ability to take up acridine
orange [15]. HMDM cells were treated for 10 min with HOCl before
washing with PBS and incubating for 20 min at 37 °C with 10 μg/ml
acridine orange in calcium-supplemented EBSS. Cells were viewed
with excitation light at 487 nm, using the Chroma multiband ﬂuores-
cence ﬁlter set 82000 and the single band blue exciter for FITC.
Changes in mitochondrial membrane potential (ΔΨm) were mea-
sured by pre-incubating HMDM cells with 100 nM tetramethylrhoda-
mine methyl ester (TMRM) for 30 min. After the 10-minute HOCl
treatment and PBS washing, the cells were immediately visualized
with excitation light at 548 nm and the orange ﬂuorescence (λem
574 nm) was photographed.
Morphological assessment of HMDM cell death was carried out
using propidium iodide (PI) following manufacturer's instructions
(BD Biosciences Clontech, USA). After HOCl treatment, HMDM cells
were washed in serum-free RPMI-1640 and incubated in dark at
room temperature with binding buffer (10 mM HEPES pH 7.4,
140 mM NaCl and 2.5 mM CaCl2) containing 4 μg/ml PI for 30 min.
The cells were viewed immediately after excitation (λex 535 nm)
and the red ﬂuorescence (λem 617 nm) was photographed.
2.7. Statistical analysis
Data was graphed and statistically analyzed using the Prism soft-
ware program (version 4.0; GraphPad Software, USA). Signiﬁcance
was conﬁrmed by a one-way analysis of variance (ANOVA), followed
by Tukey's multiple comparison test to provide a more quantitative
indication of signiﬁcance between treatments and/or time points. Sig-
niﬁcance levels are indicated in the following manner: *pb0.05;
**pb0.01; ***pb0.001. All data is representative of three separate ex-
periments. The means and standard errors of the mean (SEM) shown
within each experiment were calculated from triplicate samples.
3. Results
HOCl is highly reactive, so for these experiments the cells were ex-
posed to HOCl in EBSS for set length of time before replacing the
media with the more complex RPMI-1640 media with human serum.
This eliminated the effects of HOCl reacting with and generating new
reactants in the RPMI-1640 media.
Exposure of HMDM cells to HOCl caused a concentration-
dependent loss of cell viability (Fig. 1A). The viability loss was inde-
pendent of the length time the cells were incubated with the HOCl,
with 10-minute incubation giving the same viability loss as 60 min.
The viability loss was only signiﬁcant above a threshold concentration
of 50 μM HOCl with the viability dropping to below 20% with 200 μM
HOCl. Measurement of cell viability over the 24 hour post exposure to
HOCl showed that the majority of the viability loss was occurring
within the ﬁrst 10 min of HOCl exposure (Fig. 1B). With 100 and
150 μM HOCl, there were further 7% and 5% viability losses, which
were considerably small compared to the initial damage.Measurement of cellular ATP also showed a large and rapid loss of
ATP within 10 min of exposure to the HOCl with no further loss of
ATP occurring in the following 24 h in RPMI-1640 media with
human serum afterwards (data not shown). Similarly cellular gluta-
thione was also found to be rapidly lost with increasing HOCl levels
(data not shown).
Cellular ATP depletion is associated with the onset of necrosis
[33–34], so the propidium iodide (PI) was used to further
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dependent increase in PI ﬂuorescence intensities in HMDM cells
straight after HOCl treatment but only above 50 μM HOCl (Fig. 1C).
HOCl was causing the cells to lose membrane integrity thus allowing
the PI to enter the cells and stain them. We also noted that the cells
became larger and more swollen in appearance the higher the HOCl
(Fig. 2). These features were detectable straight after the HOCl treat-
ment and did not disappear 1 h after treatment. These morphological
changes and the cells' inability to exclude PI dye are characteristics of
necrotic cell death. This was further conﬁrmed by measuring caspase-
3 activation. We observed no concentration- or time-dependent
cleavage of the 32 kDa inactive pro-caspase-3 to the active 20 and
17 kDa caspase (Fig. 3). This ﬁnding was in agreement with measure-
ment of caspase-3 enzyme activity, which was not activated by the
HOCl treatment (data not shown). These results, together with the
morphological and ATP studies, show that HOCl-treated HMDM
cells underwent necrotic cell death.
The cell membrane is the likely primary target of the HOCl damage.
Radical damage to cells has been shown to lead to loss of calcium con-
trol triggering necrosis possibly through calcium leaking into the cellFig. 2.Morphological changes of HMDM cells after HOCl treatment. HMDM cells grown on c
After 1 hour incubation in the culture media, the cells were viewed in situ using an inverte
camera. Cells with distorted cellular membranes are marked with white arrows.[35–36]. In calcium-supplemented EBSS, HOCl treatment caused a rise
in cytosolic calcium levels above the 50 μM threshold and increased
with HOCl concentration up to 200 μM (Fig. 4A). In calcium-free EBSS,
there also was a rise in cytosolic calcium above 50 μMHOCl but no fur-
ther increasewas observed above 100 μMHOCl. The increases in calcium
due to the 100 μM HOCl were the same in both the calcium-free and
supplemented-EBSS. The results suggest that HOCl rapidly entered
HMDM cells and caused calcium release from intracellular sites, while
extracellular calcium only contributed to the cytosolic calcium pool at
higher HOCl concentrations. Treatment of the HMDM cells with the 4-
bromo-calcium ionophore A23187 caused a rapid rise in intracellular
calcium levels and triggered the loss of cell viability, but only when
the calcium levels rose 25% above the control with 3 μM A23187
(Fig. 4B). The link with calciumwas further explored by adding various
cell calcium modiﬁers. Using 150 μM HOCl in calcium-supplemented
EBSS, the HOCl-induced cytosolic rise in calcium (Fig. 4C) and cell
death (Fig. 4D) were signiﬁcantly inhibited by blockers of cell mem-
brane L-type calcium channel, nifedipine and verapamil. The T-type cal-
cium channel blocker ﬂunarizine also inhibited the HOCl-induced rise
in calcium and cell death. Interestingly, cell death was completelyover slips were treated with A) 0, B) 50, C) 100, D) 150 and E) 200 μM HOCl for 10 min.
d microscope with differential interference contrast (DIC) photos taken using a digital
Fig. 3. Caspase-3 enzyme activity is not activated in HMDM cells following HOCl treatment. A) Varying HOCl concentrations were given to HMDM cells for 10 min prior to incuba-
tion in the RPMI-1640 with human serum for 20 h. The cells were then examined for pro-caspase-3 conversion to the active 20 and 17 kDa forms by SDS-PAGE with immunoblot-
ting analysis. B) Cells in RPMI-1640 media with human serum were examined at the indicated time points for pro-caspase-3 cleavage following exposure to 150 μM HOCl.
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(RyR) that allows calcium release from endoplasmic reticulum, and by
removing extracellular calcium with EGTA. Dantrolene and EGTA were
also themost effective in reducing cytosolic calcium levels. The inhibitor
studies show that if the rise in calcium can be blocked or reduced, the
HOCl-induced cell death is inhibited.
With neuronal cells HOCl treatment has been observed to cause a
calcium-dependent lysosomal destabilization, which was mediated
by calpain [15]. With HMDM cells, HOCl also caused a loss in lyso-
some stability as shown by the loss of the intense red staining of
the acridine orange concentrated within the cellular lysosomes,
which was replaced with a green ﬂuorescence of the less concentrated
dye in the cytoplasm (Fig. 5A). Calpain inhibitors calpeptin and
SJA6017 at concentrations as low as 10 μM prevented lysosomal desta-
bilization (Fig. 5A) and loss of cell viability (Fig. 5B). Direct stabilization
of lysosomes with guanabenz and idazoxan [37] prior to 150 μM HOCl
addition also prevented the lysosome destabilization (Fig. 5A).
Since the lysosome organelles were clearly being disrupted and
we had measured a marked decrease in ATP generation, we examined
the mitochondrial function by measuring the ΔΨm with the orange
ﬂuorescence dye TMRM. HOCl caused a concentration-dependent
loss of ΔΨm (Fig. 6A). The loss of ΔΨm by the HOCl was due to the
opening of the of mitochondrial permeability transition (MPT) pore,
as pre-treatment with cyclosporin A prevented the HOCl-induced
loss of ΔΨm (Fig. 6B). Cyclosporin A binds to cyclophilin D protein
of the MPT complex inhibiting its opening [38–39]. It was surprising
that cyclosporin A also prevented the cell viability loss at concentra-
tion as low as 5 μM. It was equally surprising to ﬁnd cyclosporin A
also effectively preventing lysosome destabilization by HOCl (Fig. 7).
This shows that MPT-induced ΔΨm loss resulted in lysosomal destabi-
lization, indicating a pathway between calpain activation, MPT-
mediated ΔΨm loss and lysosome rupture resulting in macrophage
cell death.We examined further the relationship between ΔΨm and calcium
levels by adding the calcium ionophore A23187 to the HMDM cells in
calcium-supplemented EBSS without adding any HOCl (Fig. 6C).
A23187 caused a rapid loss of ΔΨm, which was prevented by 5 μM cy-
closporin A showing calcium was causing MPT pore formation in the
HMDM cells (Fig. 6C). Conversely, removal of the extracellular calcium
source using calcium-free EBSS completely prevented the loss of ΔΨm
with 150 μM HOCl (Fig. 6D). The addition of dantrolene to block endo-
plasmic reticulum calcium release prior to the addition of HOCl provided
no further protection. This suggests that HOCl-induced cytosolic calcium
increase was responsible for the ΔΨm loss in HMDM cells, and by re-
moving only the extracellular calcium source was sufﬁcient to prevent
this loss.
Preventing calcium entering the mitochondria via the ruthenium
red-sensitive mitochondrial calcium uniporter located in the organel-
le's inner membrane [40–41] during HOCl treatment also prevented
the HOCl induced loss of ΔΨm and cell viability (Fig. 6E). However,
the effect of ruthenium red was not complete at concentration as
high as 50 μM. This suggested a part of the cell death process was cal-
cium from the cytoplasm causing the mitochondrial dysfunction, but
not the key part. Blocking calpain activation with calpeptin also pre-
vented the loss of ΔΨm (Fig. 6F) suggesting that calpains were re-
sponsible for the mitochondrial dysfunction.
4. Discussion
Our data clearly shows that HOCl induced in HMDM cells a rapid
necrotic cell death characterized by PI dye inﬂux into cells (Fig. 1C),
cell swelling and lysis (Fig. 2) with no caspase-3 activation as
shown by both a lack of pro-caspase-3 conversion by immunoblotting
and the appearance of enzymatic activity (Fig. 3). Lack of caspase-3
activation by HOCl has also been reported in neuronal cells [15]. We
and others have previously shown that caspase activity is sensitive
Fig. 4. Effect of cytosolic calcium level increase on HOCl- or calcium ionophore-induced HMDM cytotoxicity. HMDM cells on cover slips were pre-incubated with 10 μM Fluo-3-AM
ester in calcium-supplemented EBSS for 40 min. The cells were treated with A) increasing HOCl concentrations in calcium-free EBSS (white bars) or calcium-supplemented EBSS
(black bars) for 10 min, or B) increasing concentrations of calcium ionophore A23187 in calcium-supplemented EBSS (white bars) for 5 min. The image of the cells was examined
under a ﬂuorescence microscope and the ﬂuorescence intensities were converted to numerical values using the ImageJ software. The cells grown in 12-well adherent Nunc plates
were analyzed for cell viability by MTT reduction after treatment with increasing concentrations of A23187 (black bars). The control values for cells with no A23187 added were not
shown. C) HMDM cells cultured on cover slips were pre-incubated with 10 μM ﬂuo-3-AM ester, whereas D) HMDM cells in 12-well adherent Nunc plates were pre-incubated with-
out ﬂuo-3-AM ester, in serum free-RPMI-1640 media, calcium-free EBSS, calcium-supplemented EBSS, or 50 μM ﬂunarizine, 50 μM verapamil, 50 μM nifedipine, 10 μM dantrolene
and 1 mM EGTA in calcium-supplemented EBSS for 40 min. After treatment with 150 μM HOCl for 10 min, the cells grown on cover slips were examined under a ﬂuorescence mi-
croscope and the ﬂuorescence intensities were converted to numerical values. The cells grown in the adherent Nunc plates were analyzed for cell viability by MTT reduction after
6 h. Data is presented as percentages of the respective controls without HOCl or A23187, and signiﬁcance is indicated from the same respective controls.
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thiols [9] and here we have shown that HOCl does cause a rapid loss
of HMDM glutathione suggesting thiol oxidation may inhibit the cas-
pase activation. Oxidative stress activation of caspase-3 via capsase-9,
normally requires apoptosome activity, which is dependent on Apaf-
1, cytochrome c release from the mitochondria and dATP or ATP,
[44–45]. The loss of ΔΨm and the effect of cyclosporine A indicate
that the MPT pore will be forming as a result of HOCl treatment
with the release of cytochrome c. However, proteolytic calpains do
appear to be active in the HMDM cells after HOCl exposure and cal-
pains have been shown to cause Apaf-1 degradation [46]. Calpains
have also been shown to cleave caspases to prevent them processing
into active forms [47–48]. Close examination of the immunoblots in
Fig. 3 does suggest a decrease in caspase-3 protein but there are no
cleaved fragments to support this mechanism. The rapid loss of cellu-
lar ATP, also observed in the HMDM cells as a result of HOCltreatment, suggests there is likely to be insufﬁcient ATP/dATP for
apoptosome formation. The evidence clearly supports a caspase inde-
pendent cell death mechanism in HMDM cells due to HOCl treatment.
What was evident was that HOCl-induced HMDM cell necrosis
was occurring via a mechanism dependent on a rise in calcium con-
centration within the cytosol (Fig. 4C and D). Calcium from both the
extracellular medium and intracellular sites contributed to the rise
in cytosolic calcium subsequent to HOCl treatment (Fig. 4A) and the
inhibition of the calcium rise, blocked the cell death (Fig. 4C and D).
Extracellular calcium entered cells via plasma membrane L- and T-
type calcium channels, which were sensitive to a range of calcium
channel blockers (Fig. 4C). Calcium was also released into the cytosol
from the endoplasmic reticulum through the RyR receptor (Fig. 4C).
The opening of these channels possibly occurred via HOCl interacting
with the essential thiols within the ion channel protein complex. The
thiol oxidizing agent 5,5′-dithio-bis(2-nitrobenzoic acid) (DTNB) has
Fig. 5. Effect of preventing calpain enzyme activity on HOCl-induced lysosomal destabilization and cell death in HMDM cells. A) HMDM cells cultured on cover slips were pre-
incubated in calcium-supplemented EBSS. The controls (ﬁrst row) had no further manipulations but the rest of the cells were treated with increasing concentrations of calpain in-
hibitors calpeptin (left column) or SJA6017 (middle column), or 10 μM of the lysosome stabilizers guanabenz or idazoxan (right column) for 1 h. The cells were treated with 150 μM
HOCl in calcium-supplemented EBSS except for the control cells, which were incubated in calcium-supplemented EBSS alone. The cells were analyzed for lysosomal integrity after
6 h by probing the cells with 10 μg/ml acridine orange for 20 min and viewing the cells under a ﬂuorescence microscope. Incubation of cells in calcium-supplemented EBSS alone for
6 h had no effect on the lysosomal stability or cell viability. B) HMDM cells were pre-incubated with increasing concentrations of calpain inhibitors calpeptin (white bars) or
SJA6017 (black bars) in calcium-supplemented EBSS for 1 h, followed by treatment with 150 μM HOCl in calcium-supplemented EBSS. The control cells were incubated in
calcium-supplemented EBSS with no HOCl added. After 6 h, the cells were analyzed for cell viability by MTT reduction. Cell viability is presented as a percentage of the respective
control where no HOCl was added, and signiﬁcance is indicated from the same respective control.
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[49] while the oxidation of thiol groups leads to activation of the
RyR on skeletal muscle sarcoplasmic reticulum membranes [50–51].
The RyR channels can also be triggered by a rise in cytosolic calcium
via the plasma membrane channels in a process called calcium-
induced calcium-release [52].Interestingly, while the L- and T-type calcium channel blockers ni-
fedipine, verapamil and ﬂunarizine only partially prevented HOCl
induced HMDM cell death, the RyR blocker dantrolene completely
prevented the cell death even with the calcium-supplemented EBSS
(Fig. 4D). This more potent effect of dantrolene was also reported
with HOCl-treated neuronal cells [15]. It is possible that dantrolene
Fig. 6. HOCl induces calcium-dependent loss of ΔΨm through MPT pore formation. HMDM cells cultured on cover slips were labeled with 100 nM TMRM in calcium-supplemented
EBSS for 30 min, during which various treatments described below were applied. Within 5 min after the treatment, the mitochondrial membrane potential (ΔΨm) was monitored
by observing the cells under ﬂuorescence microscopy and the ﬂuorescence intensities were converted to numerical values using ImageJ. The cells in the 12-well plates were exam-
ined for cell viability by MTT reduction. A) HMDM cells were pre-incubated with TMRM before the addition of varying concentrations of HOCl in calcium-supplemented EBSS for
10 min. B) HMDM cells were pre-incubated with increasing concentrations of cyclosporin A and TMRM at the same time before the addition of 150 μM HOCl in calcium-
supplemented EBSS for 10 min before analysis of the ΔΨm (white bars). Cell viability (black bars) was examined after 6 hour incubation after the treatment with HOCl. C)
HMDM cells were pre-incubated with TMRM in the presence or absence of 5 μM cyclosporin A for 30 min, after which 5 μM of the calcium ionophore A23187 in calcium-
supplemented EBSS was added to the cells for 5 min before measuring ΔΨm. D) HMDM cells pre-incubated with TMRM in either; calcium-supplemented EBSS, calcium-free
EBSS or calcium-free EBSS plus 10 μM dantrolene before the addition of 150 μM HOCl and the measuring of the ΔΨm. E) HMDM cells were incubated with TMRM plus increasing
concentrations of ruthenium red before the addition of 150 μM HOCl in calcium-supplemented EBSS for 10 min and the measurement of the ΔΨm (white bars). The cell viability
(black bars) was determined by MTT reduction 6 h after the HOCl treatment. F) HMDM cells were incubated in TMRM in the presence or absence of 10 μM calpeptin for 30 min,
after which the cells were treated with 150 μM HOCl in calcium-supplemented EBSS for 10 min. Data are presented as percentages of the respective controls in calcium-
supplemented EBSS where no HOCl, cyclosporin A, dantrolene, ruthenium red or calpeptin was added. Signiﬁcance is indicated from the same respective controls.
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plasmic reticulum.
Resting cells tightly regulate free calcium in the range of 100 to
200 nM in both the cytosol and the mitochondria. A rise in the cyto-
solic calcium concentration causes the activation of proteolytic cal-
pains, a class of calcium-dependent, ATP-independent cysteineproteases [53]. Activated calpains have been identiﬁed on human ca-
rotid plaque sections co-localizing with dead cells [54], implicating
their role in cell death and advanced plaque formation. Our calpain
inhibitor studies clearly show that calpain activation was a key
event in HOCl-induced HMDM cell necrosis (Fig. 5B). Inhibition of cal-
pain activity with speciﬁc calpain inhibitors did prevent the ΔΨm loss
Fig. 7. Cyclosporin A prevents HOCl-induced lysosomal destabilization. HMDM cells
cultured on cover slips were pre-incubated with or without 10 μM cyclosporin A for
30 min, after which the cells were treated with 150 μM HOCl in calcium-
supplemented EBSS for 10 min and incubated in the RPMI-1640 with human serum
for 6 h. The cells were analyzed for lysosomal integrity by loading the cells with
10 μg/ml acridine orange for 20 min and viewing the cells under a ﬂuorescence micro-
scope. Orange ﬂuorescencing cells indicated intake by lysosomes. The control cells
were incubated in calcium-supplemented EBSS but with no cyclosporin A or HOCl.
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completely inhibited by cyclosporin A in the HOCl treated HMDM
cells (Fig. 6B). Cyclosporin A inhibits MPT pore formation, which
causes the loss of the ΔΨm[18]. This suggests that calpains induced
MPT pore formation post HOCl treatment leading to ΔΨm loss and
subsequently cell death. With oxLDL-treated endothelial cells, acti-
vated calpains have been reported to promote MPT pore formation
via mediating Bid activation [55]. Mitochondrial calpains have also
been reported to be activated by calcium and tert-butyl hydroperoxide
in isolated rat liver mitochondria. It was proposed that mitochondrial
calpains activate MPT pore formation by cleaving proteins to generate
positively charged peptide fragments that allosterically modulate pore
opening through binding at a site that normally binds cations [56].
Other researchers have also suggested mitochondrial calcium ac-
cumulation causing MPT activation and ΔΨm loss. Calcium binds to
the negatively charged cardiolipin molecules that normally tightly
bind to the positively charged groups located in adenine nucleotide
translocator (ANT), a component of the MPT protein complex,
which leads to the release of positive charges within ANT and opening
of the gate [57]. It has also been suggested that calcium works in co-
operation with oxidizing agent to induce MPT pore formation [39,58].
We showed that preventing mitochondria taking up calcium with ru-
thenium red inhibited loss of ΔΨm and HMDM cell viability post HOCl
treatment (Fig. 6E). However, ruthenium red concentration as high as
50 μM was unable to completely prevent loss of ΔΨm and viability,
both of which could be completely prevented by only 10 μM calpeptin
(Figs. 5B and 6F). This suggests that in the present study mitochondrial
calcium accumulation played a minor role in mediating MPT pore for-
mation. Ruthenium red has been shown to block RyR receptor reconsti-
tuted in planar bilayers preventing ryanodine-induced calcium release[59]. This indicates that ruthenium red prevented loss of ΔΨm and via-
bility possibly by inhibiting cytosolic calcium increase.
Calpains have been shown to cause bleb formation and necrotic
cell death by proteolytically cleaving cytoskeletal proteins talin and
α-actinin in tert-butyl hydroperoxide-treated rat hepatocytes [60]
and actin in hydrogen peroxide-treated rat pancreatic acinar cells
[35]. Since blocking MPT pore formation with cyclosporin A also
blocked cell death and the appearance of any necrotic cell morpholo-
gy, it would appear that unspeciﬁc cellular damage by calpains is not
a feature of the HOCl-induced death in HMDM cells.
Lysosomal destabilization was completely inhibited by the calpain
inhibitors indicating that lysosomal destabilization was downstream
of calpain activation (Fig. 4A). Calpains have been suggested to mediate
lysosome destabilization in neuronal cells treated with HOCl but the
mechanism remains unclear [15]. Preventing MPT-mediated ΔΨm loss
with cyclosporin A was shown to inhibit lysosomal destabilization
(Fig. 7). This indicates that calpains induced lysosome destabilization
via opening MPT pore and causing ΔΨm loss, not via degradation of ly-
sosomal membranes. How exactlyΔΨm loss leads to lysosomal destabi-
lization is uncertain. Loss of the ΔΨm signiﬁcantly reduces the cells
ability to generate ATP. HOCl treatment of the HMDM cells did cause a
large and very rapid loss in ATP levels, which would result in failure of
the various proton pumps including those in the lysosome, hence the
observed decrease in acridine orange accumulation. This loss of ATP
generation capacity as a result of the MPT pore-dependent loss of
ΔΨm would drive the HMDM cells to a necrotic death, especially as
the loss of glutathione appears to have inhibited the caspase activity.
Lysosomal stabilizers guanabenz and idazoxan did block the lyso-
somal destabilization in HOCl-treated HMDM cells (Fig. 5A) as they
have been shown to block lysosomal destabilization in HOCl-treated
neuronal cells [15] and naphthazarin-treated astrocytes [37], but the
mechanism of their action has yet to be determined. The inhibition
of the cathepsins most likely released from ruptured lysosomes did
prevent cell death in HOCl-treated neurons suggesting that lysosome
rupture may be as important as ATP loss [15].
The data shows that HOCl causes HMDM cells to undergo necrosis
via triggering an increase in cytosolic calcium via calcium channels on
plasma and ER membranes. The calcium activates calpain, which
along with the elevated calcium triggers MPT pore formation leading
to ΔΨm loss. Without the functional mitochondria, there was a rapid
loss of ATP and lysosomal destabilization. The loss of glutathione ap-
pears to have prevented the caspase activation causing the cells to die
via necrosis with cell lysis being the main morphological feature
observed.
Acknowledgements
This work was partly funded through a project grant from the Na-
tional Heart Foundation of New Zealand and Student Research Sup-
port from the School of Biological Sciences, University of
Canterbury. Dr Whiteman was a visiting Erskine Fellow to the Univer-
sity of Canterbury during this research. We would like to thank the
staff and donors from New Zealand Blood Christchurch for the blood
to prepare the macrophage cells from. We would also like to thank
Jan McKenzie for her help in the microscopy analysis and Maggie
Tisch for her assistance in maintaining tissue culture. This manuscript
is dedicated to the memory of Alan Gieseg.
References
[1] S.M. McKenna, K.J.A. Davies, The inhibition of bacterial growth by hypochlorous
acid. Possible role in the bactericidal activity of phagocytes, Biochem. J. 254
(1988) 685–692.
[2] J.M. Albrich, C.A. McCarthy, J.K. Hurst, Biological reactivity of hypochlorous acid:
implications for microbicidal mechanisms of leukocyte myeloperoxidase, Proc.
Natl. Acad. Sci. U. S. A. 78 (1981) 210–214.
[3] M. Whiteman, A. Jenner, B. Halliwell, Hypochlorous acid-induced base modiﬁca-
tions in isolated calf thymus DNA, Chem. Res. Toxicol. 10 (1997) 1240–1246.
429Y.T. Yang et al. / Biochimica et Biophysica Acta 1823 (2012) 420–429[4] W.A. Prutz, Hypochlorous acid interactions with thiols, nucleotides, DNA, and
other biological substrates, Arch. Biochem. Biophys. 332 (1996) 110–120.
[5] M.C. Vissers, A.C. Carr, A.L.P. Chapman, Comparison of human red cell lysis by
hypochlorous and hypobromous acids: insights into the mechanism of lysis, Bio-
chem. J. 330 (1998) 131–138.
[6] D.I. Pattison, M.J. Davies, Absolute rate constants for the reaction of hypochlorous
acid with protein side chains and peptide bonds, Chem. Res. Toxicol. 14 (2001)
1453–1464.
[7] L.K. Folkes, L.P. Candeias, P. Wardman, Kinetics and mechanisms of hypochlorous
acid reactions, Arch. Biochem. Biophys. 323 (1995) 120–126.
[8] C.C. Winterbourn, Comparative reactivities of various biological compounds with
myeloperoxidase-hydrogen peroxide-chloride, and similarity of oxidant to hypo-
chlorite, Biochim. Biophys. Acta 840 (1985) 204–210.
[9] J.M. Pullar, C.C. Winterbourn, M.C.M. Vissers, Loss of GSH and thiol enzymes in
endothelial cells exposed to sublethal concentrations of hypochlorous acid, Am.
J. Physiol. Heart Circ. Physiol. 277 (1999) H1505–H1512.
[10] J.M. Pullar, M.C.M. Vissers, C.C. Winterbourn, Living with a killer: the effects of
hypochlorous acid on mammalian cells, IUMBMB Life 50 (2000) 259–266.
[11] I. Tabas, Macrophage apoptosis in atherosclerosis: consequences on plaque pro-
gression and the role of endoplasmic reticulum stress, Antioxid. Redox Signal.
11 (2009) 2333–2339.
[12] A. Daugherty, J.L. Dunn, D.L. Rateri, J.W. Heinecke, Myeloperoxidase, a catalyst for
lipoprotein oxidation, is expressed in human atherosclerosis lesions, J. Clin. In-
vest. 94 (1994) 437–444.
[13] S. Sugiyama, Y. Okada, G.K. Sukhova, R. Virmani, J.W. Heinecke, P. Libby, Macro-
phage myeloperoxidase regulation by granulocyte macrophage colony-
stimulating factor in human atherosclerosis and implications in acute coronary
syndromes, Am. J. Pathol. 158 (2001) 879–891.
[14] C. King, M. Jefferson, E. Thomas, Secretion and inactivation of myeloperoxidase by
isolated neutrophils, J. Leukoc. Biol. 61 (1997) 293–302.
[15] Y.W. Yap, M. Whiteman, B.H. Bay, Y.H. Li, F.S. Sheu, R.Z. Qi, C.H. Tan, N.S. Cheung,
Hypochlorous acid induces apoptosis of cultured cortical neurons through activa-
tion of calpains and rupture of lysosomes, J. Neurochem. 98 (2006) 1597–1609.
[16] S. Sugiyama, K. Kugiyama, M. Aikawa, S. Nakamura, H. Ogawa, P. Libby, Hypo-
chlorous acid, a macrophage product, induces endothelial apoptosis and tissue
factor expression— involvement of myeloperoxidase-mediated oxidant in plaque
erosion and thrombogenesis, Arterioscler. Thromb. Vasc. Biol. 24 (2004)
1309–1314.
[17] M.C.M. Vissers, J.M. Pullar, M.B. Hampton, Hypochlorous acid causes caspase acti-
vation and apoptosis or growth arrest in human endothelial cells, Biochem. J. 344
(1999) 443–449.
[18] M. Whiteman, P. Rose, J.L. Siau, N.S. Cheung, G.S. Tan, B. Halliwell, J.S. Armstrong,
Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human
hepatoma HEPG2 and human fetal liver cells: role of mitochondrial permeability
transition, Free Radical Biol. Med. 38 (2005) 1571–1584.
[19] S.P. Gieseg, D.S. Leake, E.M. Flavall, Z. Amit, L. Reid, Y. Yang, Macrophage antioxidant
protection within atherosclerotic plaques, Front. Biosci. 14 (2009) 1230–1246.
[20] S.P. Gieseg, J. Whybrow, D. Glubb, C. Rait, Protection of U937 cells from free rad-
ical damage by the macrophage synthesized antioxidant 7,8 dihydroneopterin,
Free Radical Res. 35 (2001) 311–318.
[21] M. Kappler, A.J. Gerry, E. Brown, L. Reid, D.S. Leake, S.P. Gieseg, Aqueous peroxyl
radical exposure to THP-1 cells causes glutathione loss followed by protein oxida-
tion and cell death without increased caspase-3 activity, Biochim. Biophys. Acta
1773 (2007) 945–953.
[22] S.J. Hardwick, L. Hegyi, K. Clare, N.S. Law, K.L.H. Carpenter, M.J. Mitchinson, J.N.
Skepper, Apoptosis in human monocyte-macrophages exposed to oxidised low
density lipoprotein, J. Pathol. 179 (1996) 294–302.
[23] R. Asmis, J.G. Begley, Oxidized LDL promotes peroxide-mediated mitochondrial
dysfunction and cell death in human macrophages — a caspase-3-independent
pathway, Circ. Res. 92 (2003) E20–E29.
[24] S.P. Gieseg, Z. Amit, Y.T. Yang, A. Shchepetkina, H. Katouah, Oxidant production,
oxLDL uptake, and CD36 levels in human monocyte derived macrophages are
down regulated by the macrophage generated antioxidant 7,8-dihydroneopterin,
Antioxid. Redox Signal. 13 (2010) 1525–1534.
[25] V. Borutaite, G.C. Brown, Nitric oxide induces apoptosis via hydrogen peroxide, but ne-
crosis via energy and thiol depletion, Free Radical Biol. Med. 35 (2003) 1457–1468.
[26] C.A. Firth, Y. Yang, S.P. Gieseg, Lipid oxidation predominates over protein hydro-
peroxide formation in human monocyte-derived macrophages exposed to aque-
ous peroxyl radicals, Free Radical Res. 41 (2007) 839–848.
[27] J. Van-Den-Berg, C. Winterbourn, Measurement of reaction products from hypo-
chlorous acid and unsaturated lipids, Methods Enzymol. 233 (1994) 639–649.
[28] T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application
to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55–63.
[29] W. Furst, S. Hallstrom, Simultaneous determination of myocardial nucleotides, nu-
cleosides, purine-bases and creatine-phosphate by ion-pair high-performance
liquid-chromatography, J. Chromatogr. Biomed. Appl. 578 (1992) 39–44.
[30] I.A. Cotgreave, P. Moldeus, Methodologies for the application of monobromobi-
mane to the simultaneous analysis of soluble and protein thiol components of bi-
ological systems, J. Biochem. Biophys. Methods 13 (1986) 231–249.
[31] M.B. Hampton, I. Stamenkovic, C.C. Winterbourn, Interaction with substrate sensitises
caspase-3 to inactivation by hydrogen peroxide, FEBS Lett. 517 (2002) 229–232.
[32] J.P.Y. Kao, A.T. Harootunian, R.Y. Tsien, Photochemically generated cytosolic calcium
pulses and their detection by FLUO-3, J. Biol. Chem. 264 (1989) 8179–8184.[33] Y. Eguchi, S. Shimizu, Y. Tsujimoto, Intracellular ATP levels determine cell death
fate by apoptosis or necrosis, Cancer Res. 57 (1997) 1835–1840.
[34] T. Tatsumi, J. Shiraishi, N. Keira, K. Akashi, A. Mano, S. Yamanaka, S. Matoba, S.
Fushiki, H. Fliss,M. Nakagawa, Intracellular ATP is required formitochondrial apopto-
tic pathways in isolated hypoxic rat cardiac myocytes, Cardiovasc. Res. 59 (2003)
428–440.
[35] H. Weber, S. Huhns, F. Luthen, L. Jonas, P. Schuff-Werner, Calpain activation con-
tributes to oxidative stress-induced pancreatic acinar cell injury, Biochem. Phar-
macol. 70 (2005) 1241–1252.
[36] V.H. Moreau, R.F. Castilho, S.T. Ferreira, P.C. Carvalho-Alves, Oxidative damage to
sarcoplasmic reticulum Ca2+-ATPase at submicromolar iron concentrations: evi-
dence for metal-catalyzed oxidation, Free Radical Biol. Med. 25 (1998) 554–560.
[37] S.H. Choi, D.H. Choi, J.J. Lee, M.S. Park, B.G. Chun, Imidazoline drugs stabilize lyso-
somes and inhibit oxidative cytotoxicity in astrocytes, Free Radical Biol. Med. 32
(2002) 394–405.
[38] K. Woodﬁeld, A. Ruck, D. Brdiczka, A.P. Halestrap, Direct demonstration of a spe-
ciﬁc interaction between cyclophilin-D and the adenine nucleotide translocase
conﬁrms their role in the mitochondrial permeability transition, Biochem. J. 336
(1998) 287–290.
[39] G.P. McStay, S.J. Clarke, A.P. Halestrap, Role of critical thiol groups on the matrix
surface of the adenine nucleotide translocase in the mechanism of the mitochon-
drial permeability transition pore, Biochem. J. 367 (2002) 541–548.
[40] Y. Kirichok, G. Krapivinsky, D.E. Clapham, The mitochondrial calcium uniporter is
a highly selective ion channel, Nature 427 (2004) 360–364.
[41] D.R. Trollinger, W.E. Cascio, J.J. Lemasters, Mitochondrial calcium transients in
adult rabbit cardiac myocytes: inhibition by ruthenium red and artifacts caused
by lysosomal loading of Ca2+-indicating ﬂuorophores, Biophys. J. 79 (2000)
39–50.
[42] M.B. Hampton, B. Fadeel, S. Orrenius, Redox regulation of the caspases duringapopto-
sis, Ann. N. Y. Acad. Sci. 854 (1998) 328–335.
[43] S.K. Baird, L. Reid, M. Hampton, S.P. Gieseg, OxLDL induced cell death is inhibited
by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but
not THP-1 cells, Biochim. Biophys. Acta 1745 (2005) 361–369.
[44] G. Kroemer, S.J. Martin, Caspase-independent cell death, Nat. Med. 11 (2005)
725–730.
[45] X.S. Liu, C.N. Kim, J. Yang, R. Jemmerson, X.D. Wang, Induction of apoptotic pro-
gram in cell-free extracts: requirement for dATP and cytochrome c, Cell 86
(1996) 147–157.
[46] C. Reimertz, D. Kogel, S. Lankiewicz, M. Poppe, J.H.M. Prehn, Ca2+-induced inhibi-
tion of apoptosis in human SH-SY5Y neuroblastoma cells: degradation of apopto-
tic protease activating factor-1 (APAF-1), J. Neurochem. 78 (2001) 1256–1266.
[47] S. Lankiewicz, C.M. Luetjens, N.T. Bui, A.J. Krohn, M. Poppe, G.M. Cole, T.C. Saido,
J.H.M. Prehn, Activation of calpain I converts excitotoxic neuron death into a
caspase-independent cell death, J. Biol. Chem. 275 (2000) 17064–17071.
[48] N. Bizat, J.M. Hermel, S. Humbert, C. Jacquard, C. Creminon, C. Escartin, F. Saudou,
S. Krajewski, P. Hantraye, E. Brouillet, In vivo calpain/caspase cross-talk during 3-
nitropropionic acid-induced striatal degeneration — implication of a calpain-
mediated cleavage of active caspase-3, J. Biol. Chem. 278 (2003) 43245–43253.
[49] D.L. Campbell, J.S. Stamler, H.C. Strauss, Redox modulation of L-type calcium
channels in ferret ventricular myocytes — dual mechanism regulation by nitric
oxide and S-nitrosothiols, J. Gen. Physiol. 108 (1996) 277–293.
[50] J.H. Sun, J.P. Eu, J.S. Stamler, G. Meissner, Classes of thiols that inﬂuence the activ-
ity of the skeletal muscle calcium release channel, J. Biol. Chem. 276 (2001)
15625–15630.
[51] T.G. Favero, J. Webb, M. Papiez, E. Fisher, R.J. Trippichio, M. Broide, J.J. Abramson,
Hypochlorous acid modiﬁes calcium release channel function from skeletal muscle
sarcoplasmic reticulum, J. Appl. Physiol. 94 (2003) 1387–1394.
[52] C. Maack, B. O'Rourke, Excitation–contraction coupling and mitochondrial ener-
getics, Basic Res. Cardiol. 102 (2007) 369–392.
[53] T.C. Saido, H. Sorimachi, K. Suzuki, Calpain: new perspectives in molecular diver-
sity and physiological–pathological involvement, FASEB J. 8 (1994) 814–822.
[54] I. Goncalves, M. Nitulescu, T.C. Saido, N. Dias, L.M. Pedro, J.F.E. Fernandes, M.P.S.
Ares, I. Porn-Ares, Activation of calpain-1 in human carotid artery atherosclerotic
lesions, BMC Cardiovasc. Disord. 9 (2009).
[55] C. Vindis, M. Elbaz, I. Escargueil-Blanc, N. Auge, A. Heniquez, J.C. Thiers, A. Negre-
Salvayre, R. Salvayre, Two distinct calcium-dependent mitochondrial pathways
are involved in oxidized LDL-induced apoptosis, Arterioscler. Thromb. Vasc.
Biol. 25 (2005) 639–645.
[56] H.I. Aguilar, R. Botla, A.S. Arora, S.F. Bronk, G.J. Gores, Induction of the mitochon-
drial permeability transition by protease activity in rats: a mechanism of hepato-
cyte necrosis, Gastroenterology 110 (1996) 558–566.
[57] N. Brustovetsky, M. Klingenberg, Mitochondrial ADP/ATP carrier can be reversibly
converted into a large channel by Ca2+, Biochemistry 35 (1996) 8483–8488.
[58] B.V. Chernyak, V.N. Dedov, V.Y. Chernyak, Ca2+-triggered membrane-
permeability transition in deenergized mitochondria from rat-liver, FEBS Lett.
365 (1995) 75–78.
[59] J. Ma, K. Anderson, R. Shirokov, R. Levis, A. Gonzalez, M. Karhanek, M.M. Hosey, G.
Meissner, E. Rios, Effects of perchlorate on the molecules of excitation–contrac-
tion coupling of skeletal and cardiac-muscle, J. Gen. Physiol. 102 (1993) 423–448.
[60] H. Miyoshi, K. Umeshita, M. Sakon, S. ImajohOhmi, K. Fujitani, M. Gotoh, E. Oiki, J.
Kambayashi, M. Monden, Calpain activation in plasma membrane bleb formation
during tert-butyl hydroperoxide-induced rat hepatocyte injury, Gastroenterology
110 (1996) 1897–1904.
